Rejuvenate Biomed

  • Home
  • Team
  • Science
  • History
  • News
  • Events
  • Contact
  • Home
  • Team
  • Science
  • History
  • News
  • Events
  • Contact
Home News

Stay up-to-date about our progress and other news

VLAIO funding (Baekeland mandate)

Rejuvenate Biomed supports Sven Bulterijs in his PhD under guidance of Prof. Bart Braeckman at Ghent University. His work will focus on C. elegans research in the context of aging.

LEARN MORE

Strategic partnership with PhaRA Consulting to navigate the regulatory pathways

As a partner, PhaRA Consulting will use their regulatory affairs expertise to support Rejuvenate Biomed’s clinical and commercial objectives.

LEARN MORE

VLAIO funding €1.16 million to facilitate research

Rejuvenate Biomed has been awarded a €1,160,000 grant from VLAIO to accelerate drug development for healthy aging.

LEARN MORE

Rejuvenate Biomed in radio and television magazine

Interview with Ann Beliën on healthy for life.

LEARN MORE

Rejuvenate Biomed on national radio

Radio 1 interviewed Ann Beliën in fifty-fifty, a podcast for over-fifties.

LEARN MORE
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

Rejuvenate Biomed

Rejuvenate Biomed is an AI-enabled clinical-stage company developing combination drugs to promote healthy aging.

LET'S CONNECT

Agoralaan A-bis
3590 Diepenbeek
Belgium

View map

One Broadway, Cambridge
MA 02141
USA

View map

info@rejuvenatebiomed.com

© Copyright 2024 Rejuvenate Biomed NV. All Right Reserved.
  • Privacy Policy
  • Cookie Policy

This website uses cookies to enhance your browsing experience. More information.